BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today ...

As the field continues to evolve, CAR-T cell therapies hold significant potential for revolutionizing the treatment landscape of CRC. Fig 1. Overview of the CAR-T cell therapy process ... in the ...

These findings offer hope for more effective treatment ... transition (EMT), a process crucial for cancer spread. This complex interplay between oral bacteria and cancer cells offers new insights ...

Pioneering scientist Michal Schwartz of the Weizmann Institute says that she and her team of researchers are close to developing a groundbreaking immunotherapy treatment that could help boost the ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

In an increasingly energy-driven world, technology developments are being sought after to reduce energy consumption in ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

Operator instructions] The conference is being recorded. [Operator instructions] A recording of the conference call, ...

Sumitomo Chemical Company, Limited ( OTCPK:SOMMY) Q3 2025 Results Conference Call February 3, 2025 3:00 AM ET Takato Watabe - Morgan Stanley MUFG Securities Makio Yamada - Mizuho Securities Go ...

Scorpius Holdings, Inc (NYSE American: SCPX) ("Scorpius" or "the Company"), an integrated contract development and manufacturing organization ("CDMO") ...